Apiam Animal Health Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	206.92	204.66	191.76	157.06	126.18
Revenue Growth (YoY)	1.11%	6.73%	22.09%	24.47%	6.63%
Cost of Revenue	160.04	158.16	152.41	122.72	100.87
Gross Profit	46.88	46.5	39.35	34.34	25.32
Selling, General & Admin	-	-	-	-	2.14
Other Operating Expenses	21.69	22.16	22.24	18.2	8.54
Operating Expenses	34.44	34.14	32.47	26.55	17.1
Operating Income	12.44	12.36	6.88	7.78	8.21
Interest Expense	-5.65	-5.52	-3.77	-1.57	-1.18
Earnings From Equity Investments	-0.01	0.05	0.05	0.09	0.08
Other Non Operating Income (Expenses)	0.62	-	-	-	-
EBT Excluding Unusual Items	7.4	6.89	3.16	6.3	7.12
Merger & Restructuring Charges	-	-	-0.32	-	-0.17
Impairment of Goodwill	-3.45	-	-	-	-
Gain (Loss) on Sale of Assets	0.58	0.17	0.32	0.17	0.02
Asset Writedown	-1.68	-	-	-	-
Pretax Income	2.86	7.06	3.17	6.47	6.97
Income Tax Expense	2	2.15	1	1.93	2.02
Earnings From Continuing Operations	0.86	4.91	2.17	4.54	4.95
Minority Interest in Earnings	-0.03	0.02	0.11	0.1	0.09
Net Income	0.83	4.93	2.28	4.64	5.04
Net Income to Common	0.83	4.93	2.28	4.64	5.04
Net Income Growth	-83.13%	116.56%	-50.92%	-7.88%	22.98%
Shares Outstanding (Basic)	181	179	175	136	121
Shares Outstanding (Diluted)	187	182	178	138	122
Shares Change (YoY)	2.66%	2.38%	28.68%	13.16%	6.75%
EPS (Basic)	0.00	0.03	0.01	0.03	0.04
EPS (Diluted)	0.00	0.03	0.01	0.03	0.04
EPS Growth	-83.77%	111.73%	-61.91%	-18.64%	15.36%
Free Cash Flow	11.75	14.1	9.55	10.72	8.95
Free Cash Flow Per Share	0.06	0.08	0.05	0.08	0.07
Dividend Per Share	0.020	0.020	-	0.016	0.024
Dividend Growth	-	-	-	-33.33%	20.00%
Gross Margin	22.66%	22.72%	20.52%	21.86%	20.06%
Operating Margin	6.01%	6.04%	3.59%	4.96%	6.51%
Profit Margin	0.40%	2.41%	1.19%	2.95%	3.99%
Free Cash Flow Margin	5.68%	6.89%	4.98%	6.82%	7.09%
EBITDA	19.4	19.34	12.98	12.82	12.11
EBITDA Margin	9.37%	9.45%	6.77%	8.16%	9.60%
D&A For EBITDA	6.96	6.98	6.1	5.04	3.9
EBIT	12.44	12.36	6.88	7.78	8.21
EBIT Margin	6.01%	6.04%	3.59%	4.96%	6.51%
Effective Tax Rate	69.79%	30.50%	31.43%	29.84%	28.99%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.